» Articles » PMID: 8204392

Noninvasive Identification of Left Main and Three-vessel Coronary Artery Disease by Thallium-201 Single Photon Emission Computed Tomography During Adenosine Infusion

Overview
Journal Ann Nucl Med
Date 1994 Feb 1
PMID 8204392
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced coronary artery disease, defined as left main or three-vessel coronary disease, was identifiable noninvasively by means of adenosine Tl-201 single photon emission tomography. Among 75 consecutive patients with angiographically documented coronary artery disease, there were 11 patients with the presence (group 1) and 64 patients with the absence (group 2) of advanced coronary artery disease. The lung-to-heart ratio (L/H ratio) of Tl-201 uptake was calculated as the fraction of average Tl-201 counts per pixel in the lung divided by those in the myocardium. The left ventricular dilation ratio (LVDR) was determined as a ratio of left ventricular cavity size in the early image to that in the delayed image. The patients in group 1 had more defects (2.3 +/- 0.6 seg. vs. 0.9 +/- 0.7 seg., p < 0.001), a higher L/H ratio (35 +/- 4% vs. 28 +/- 5%, p < 0.001) and a higher LVDR (1.13 +/- 0.04 vs. 1.06 +/- 0.04, p < 0.001) than those in group 2. The diagnostic accuracy of the identification of advanced coronary artery disease was 89% by perfusion defects, 68% by L/H ratio and 81% by LVDR. Stepwise discriminant analysis revealed that LVDR (F = 36.2, p < 0.0001) and perfusion defects (F = 8.9, p < 0.004) were the significant and independent discriminators of advanced coronary disease. Identification of patients with left main or three-vessel coronary disease was enhanced by additional analysis of cavity dilation of the left ventricle and increased Tl-201 activity in the lung.

Citing Articles

Use of Extracorporeal Membrane Oxygenation to Rescue Patients With Refractory Ventricular Arrhythmia in Acute Myocardial Infarction.

Yeh C, Wang C, Tsai P, Wu C, Lin Y, Chen Y Medicine (Baltimore). 2015; 94(30):e1241.

PMID: 26222862 PMC: 4554118. DOI: 10.1097/MD.0000000000001241.


Contemporary relevance of TID: Based on the company it keeps.

Bourque J J Nucl Cardiol. 2015; 22(3):535-8.

PMID: 25832984 PMC: 5485415. DOI: 10.1007/s12350-015-0122-7.


Transient ischemic dilation: a powerful diagnostic and prognostic finding of stress myocardial perfusion imaging.

McLaughlin M, Danias P J Nucl Cardiol. 2002; 9(6):663-7.

PMID: 12466791 DOI: 10.1067/mnc.2002.124979.


Predictive potential of noninvasive methods, inclusive of exercise SPECT Tc99m MIBI imaging, in recognition of high-risk patients with left main coronary artery stenosis.

Kostkiewicz M, Tracz W, Przewlocki T, Kawalec E Int J Cardiovasc Imaging. 2002; 17(5):347-52.

PMID: 12025948 DOI: 10.1023/a:1011969417896.


Improved detection of left main coronary artery disease with attenuation-corrected SPECT.

Duvernoy C, Ficaro E, Karabajakian M, ROSE P, Corbett J J Nucl Cardiol. 2001; 7(6):639-48.

PMID: 11144479 DOI: 10.1067/mnc.2000.109454.

References
1.
Dash H, Massie B, Botvinick E, Brundage B . The noninvasive identification of left main and three-vessel coronary artery disease by myocardial stress perfusion scintigraphy and treadmill exercise electrocardiography. Circulation. 1979; 60(2):276-84. DOI: 10.1161/01.cir.60.2.276. View

2.
Wackers F . Adenosine or dipyridamole: which is preferred for myocardial perfusion imaging?. J Am Coll Cardiol. 1991; 17(6):1295-6. DOI: 10.1016/s0735-1097(10)80138-x. View

3.
Nishimura S, Mahmarian J, Verani M . Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med. 1992; 33(9):1600-7. View

4.
Kurata C, Tawarahara K, Taguchi T, Sakata K, Yamazaki N, Naitoh Y . Lung thallium-201 uptake during exercise emission computed tomography. J Nucl Med. 1991; 32(3):417-23. View

5.
Takeishi Y, Meguro M, Hoshi H, Masakane I, Ikeda K, Tsuiki K . The relationship between chest pain during thallium-201 scintigraphy with dipyridamole and myocardial ischemia. Jpn Circ J. 1991; 55(5):465-72. DOI: 10.1253/jcj.55.465. View